US EditionMedicare announces price cuts for 15 prescription drugs, including Ozempic
The negotiated drug prices will save Medicare $12 billion and reduce out-of-pocket costs by $685 million starting in 2027 under the Inflation Reduction Act.
- On Tuesday, the Centers for Medicare and Medicaid Services announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy, with cuts taking effect in 2027.
- Created under the Inflation Reduction Act, the negotiation program cuts prices following last year’s deals on 10 prescription drugs amid affordability concerns.
- The negotiated list shows steep cuts for several high-cost medicines, including Ozempic, Rybelsus, and Wegovy at $274 for a 30-day supply, down from the $959 list price, and the 15 drugs accounted for $42.5 billion, or 15%, of Medicare Part D spending in 2024.
- CMS said the discounts will save taxpayers $12 billion and reduce Medicare enrollees’ out-of-pocket costs by $685 million in 2027.
- The announcement contrasts with President Donald Trump’s voluntary deal approach, as Trump recently announced a Novo Nordisk deal with a $250 price while drugmakers have unsuccessfully challenged the statutory program.
16 Articles
16 Articles
Trump admin says drug price negotiations will save Medicare roughly $12 billion
By Tami Luhby, CNN (CNN) — Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday evening. The savings are estimated based on what Medicare spent on the medicines last year. Medicare enrollees are expected to save $685 million on out-of-pocket costs when the prices take effect in 2027. Ozempic and Wegovy…
Trump admin says drug price negotiations will save Medicare roughly $12 billion | News Channel 3-12
By Tami Luhby, CNN (CNN) — Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday evening. The savings are estimated based on what Medicare spent on the medicines last year. Medicare enrollees are expected to save $685 million on out-of-pocket costs when the prices take effect in 2027. Ozempic and Wegovy…
Trump admin says drug price negotiations will save Medicare roughly $12 billion
Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday evening. The savings are estimated based on what Medicare spent on the medicines last year.
US shaves 36% off Medicare spending on 15 high-priced medicines
The U.S. Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those medications compared with recent annual spending, or about $8.5 billion in net covered prescription costs.
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
